title: Radiation therapy with/without simultaneous weekly 5 F.U. in locally recurrent carcinoma of the recto-sigmoid.
abstract: Forty-eight patients received radiation therapy to the pelvis for locally recurrent carcinoma of the recto-sigmoid. The average duration before the development of local recurrence in the pelvis after curative surgery was 18 months. Thirty-seven patients had undergone a previous adbominoperineal resection. Twenty-five patients had Dukes' Stage-C carcinoma. Twenty-one patients had Stage-B and only two patients had Stage-A carcinoma of the rectosigmoid according to the Dukes' classification. All patients received radiation therapy to the pelvis to an average total dose of 5,000 rads in 25 to 28 fractions over a period of five to five and one half weeks. Twenty-three patients also received simultaneous weekly 5 F.U. by a single I.V. bolus of 1000mg to potentiate the action of radiation therapy. The treatments were well tolerated. The major complication was diarrhea, which responded satisfactorily to antidiarrheals such as Lomotil or Immodium tablets. Eighty per cent of the patients had pain relief. The median survival was 18 months for the patients receiving radiation therapy alone, but the patients treated with both radiation therapy and 5 F.U. had an average survival of 21 months and better palliation of symptoms.
authors.forename: P P
authors.initials: PP
authors.lastname: Sinha
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012811:Sigmoid Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
chemical_list: D005472:Fluorouracil